U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT06903741) titled 'New Preservative-free Combination of Trehalose, Sodium Hyaluronate and N-acetyl-aspartyl-glutamate (NAAGA) in Dry Eye' on March 21.

Brief Summary: The goal of this prospective, non-randomized, non-comparative, monocentric PMCF study is to assess the performance of a new preservative-free combination of trehalose, sodium hyaluronate and NAAGA on DED at 6 months in 30 patients having dry eye disease.

The main questions it aims to answer are:

* To assess the performance and safety of T2769 at 3 months and 6 months.

* To assess patient compliance to therapy.

* To assess the occurrence of dry eye flares. Participants will be asked to...